Ardelyx real-world study shows phosphate reductions after Xphozah initiation in dialysis patients
Bitget2026/10/23 20:01- Ardelyx presented real-world results showing lower serum phosphate levels following XPHOZAH (tenapanor) initiation at ASN Kidney Week 2026.
- The analysis covered more than 1,400 adults on dialysis, with phosphate reductions observed over six months.
- Similar reductions occurred across evaluated groups, including patients taking XPHOZAH without phosphate binders or alongside a single binder.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin (BTC) Tanks Toward $80K, Ripple (XRP) Loses Key Support: Weekend Watch
WLD Price Prediction: Worldcoin Eyes $12 as Cloudflare Partnership Advances
Last week, retail investors made a "record-breaking" dip buy of US chip leveraged ETFs, but this week they plummeted.
Last week, retail investors poured $6.1 billion into 3x leveraged chip ETFs, but suffered a 20.5% single-day plunge this Thursday, almost perfectly coinciding with the start of the rapid downturn. The cumulative decline in October has exceeded 43%, far surpassing the 15.9% loss of non-leveraged products during the same period. The root cause lies in the market’s skepticism toward AI investment returns. The most significant uncertainty is whether aggressive spending by tech giants will actually deliver on profit expectations, while the use of leverage has exponentially magnified the cost of this misjudgment.
Africa’s payment giant backed by SoftBank is rushing to list in the US! Opay (OPAY.US) plans to raise $336 million, with its valuation possibly exceeding $4 billion
The payment platform Opay Ltd., which focuses on the Nigerian market, plans to raise up to 336 million dollars through an initial public offering (IPO).
Crypto prices
More
